ATLANTA, Oct. 6 (HSMN NewsFeed) — CryoLife, Inc., (NYSE: CRY ) an implantable biological pharmaceutical device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug…
Devices, Cardiology, FDA
CryoLife, CryoValve SG, heart valve

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves”
Leave a Comment